These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hepatitis in children with tuberculosis: a case report and review of the literature. Sanchez-Codez M; Hunt WG; Watson J; Mejias A BMC Pulm Med; 2020 Jun; 20(1):173. PubMed ID: 32546255 [TBL] [Abstract][Full Text] [Related]
43. [Administration of antituberculous drugs to subjects with basic diseases. 2. Clinical studies of INH and RFP therapy on tuberculous patients with liver diseases]. Yamazaki M Kekkaku; 1987 Dec; 62(12):667-71. PubMed ID: 3448352 [No Abstract] [Full Text] [Related]
44. [Chemotherapy of pulmonary tuberculosis with liver damage]. Overrath H Prax Pneumol; 1973 Mar; 27(3):182-90. PubMed ID: 4699468 [No Abstract] [Full Text] [Related]
45. [Liver changes during treatment with antitubercular agents]. Velojic D; Jankovic Z; MArsenic B Plucne Bolesti Tuberk; 1975; 27(1-2):53-60. PubMed ID: 1161927 [No Abstract] [Full Text] [Related]
46. Advances in chemotherapy for pulmonary tuberculosis. Tala E Eur J Respir Dis; 1982 Mar; 63(2):81-3. PubMed ID: 7067766 [No Abstract] [Full Text] [Related]
47. [Successful treatment of tuberculosis in a patient with poor compliance. Intermittent controlled treatment in general practice]. Achermann R; Karrer W Praxis (Bern 1994); 1997 Dec; 86(50):1994-7. PubMed ID: 9465727 [TBL] [Abstract][Full Text] [Related]
48. [Pharmacology, toxicology and clinical use of pyrazinamide (author's transl)]. Zierski M Prax Klin Pneumol; 1981 Dec; 35(12):1075-1105. PubMed ID: 6808484 [No Abstract] [Full Text] [Related]
49. [Modern status of chemotherapy of tuberculosis]. Krieger HG Offentl Gesundheitswes; 1989 Nov; 51(11):698-704. PubMed ID: 2532723 [TBL] [Abstract][Full Text] [Related]
50. To treat or not to treat? Implementation of DOTS in Central Asia. Cox H; Hargreaves S Lancet; 2003 Mar; 361(9359):714-5. PubMed ID: 12620733 [No Abstract] [Full Text] [Related]
51. [The impact of antituberculosis drugs upon liver function in patients with positive HBVM]. Chen GQ Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):89-90, 126. PubMed ID: 2791129 [TBL] [Abstract][Full Text] [Related]
52. [Assessment of hepatotoxicity of antitubercular drugs in patients with pulmonary tuberculosis abusing alcohol]. Grymiński J; Lyczewska J; Styszewska H; Walczak J Gruzlica; 1969 Aug; 37(8):749-57. PubMed ID: 5352301 [No Abstract] [Full Text] [Related]
53. [Modern treatment of tuberculosis]. Gulsvik A Tidsskr Nor Laegeforen; 1987 Mar; 107(9):867-9. PubMed ID: 3590128 [No Abstract] [Full Text] [Related]
54. [Toxicity in the current treatment of pulmonary tuberculosis in children]. Altet Gómez MN; Alcáide Megías J; Boque Genovard MA An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974 [TBL] [Abstract][Full Text] [Related]
55. Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs. Valenzuela P; Valenzuela MT; Ponce J Bull Pan Am Health Organ; 1988; 22(2):175-83. PubMed ID: 3048504 [No Abstract] [Full Text] [Related]
56. [Clinically apparent liver damage during brief tuberculosis therapy]. Estay S; Armas Merino R; Vega C; Soto JR Rev Med Chil; 1981 Oct; 109(10):941-4. PubMed ID: 7344017 [No Abstract] [Full Text] [Related]
57. [Important points in therapy of pulmonary tuberculosis and atypical mycobacterium respiratory infections]. Kawahara S Nihon Naika Gakkai Zasshi; 1998 Feb; 87(2):297-302. PubMed ID: 9549327 [No Abstract] [Full Text] [Related]
58. [Unusual therapeutic approach in treatment of pulmonary tuberculosis in six year old girl]. Saracević E; Dizdarević A; Mulaosmanović V Med Arh; 2004; 58(3):183-4. PubMed ID: 15484863 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for drug induced hepatitis with first-line antituberculosis drugs in hospitalized patients of pulmonary tuberculosis. Pore SM; Shinde K J Postgrad Med; 2014; 60(1):90-2. PubMed ID: 24625953 [No Abstract] [Full Text] [Related]